Should activated vitamin D be used in patients with end-stage renal disease and low levels of parathyroid hormone?

Myles Wolf

doi:10.1111/j.1525-139X.2011.00914.x

Should activated vitamin D be used in patients with end-stage renal disease and low levels of parathyroid hormone?

Myles Wolf^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	428-430
Number of pages	3
Journal	Seminars in Dialysis
Volume	24
Issue number	4
DOIs	https://doi.org/10.1111/j.1525-139X.2011.00914.x
State	Published - Jul 2011
Externally published	Yes

ASJC Scopus subject areas

Nephrology

Access to Document

10.1111/j.1525-139X.2011.00914.x

Cite this

@article{72dfa25cd10545819c70a1059de4f631,

title = "Should activated vitamin D be used in patients with end-stage renal disease and low levels of parathyroid hormone?",

author = "Myles Wolf",

year = "2011",

month = jul,

doi = "10.1111/j.1525-139X.2011.00914.x",

language = "English (US)",

volume = "24",

pages = "428--430",

journal = "Seminars in Dialysis",

issn = "0894-0959",